Markets:

Overview

News

Currencies

International

Treasuries

Co-Diagnostics, Inc. - Common Stock (NQ:CODX)

3.380 +0.260 (+8.33%)

Streaming Delayed Price Updated: 1:48 PM EDT, Jun 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Co-Diagnostics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 16, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

May 26, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Examining the Future: Co-Diagnostics's Earnings Outlook ↗

May 07, 2025

Via Benzinga

Uncovering Potential: Co-Diagnostics's Earnings Preview ↗

March 26, 2025

Via Benzinga

Peering Into Co-Diagnostics's Recent Short Interest ↗

April 02, 2024

Via Benzinga

Co-Diagnostics: Q4 Earnings Insights ↗

March 14, 2024

Via Benzinga

This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday ↗

April 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 01, 2025

Via Benzinga

Top movers in Tuesday's after hours session ↗

March 25, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version ↗

February 24, 2025

Co-Diagnostics plans to submit an enhanced COVID-19 test for FDA clearance, addressing stability concerns and integrating platform advancements.

Via Benzinga

Earnings Preview: Co-Diagnostics ↗

March 13, 2024

Via Benzinga

Preview: Co-Diagnostics's Earnings ↗

May 10, 2023

Via Benzinga

Co-Diagnostics Earnings Perspective: Return On Invested Capital ↗

March 17, 2023

Via Benzinga

Preview: Co-Diagnostics's Earnings ↗

March 15, 2023

Via Benzinga

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 14, 2025

Via Benzinga

CODX Stock Earnings: Co-Diagnostics Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

CODX stock results show that Co-Diagnostics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 10, 2024

Via Benzinga

Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 06, 2024

Via Benzinga

CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q4 2023 ↗

March 14, 2024

CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 10, 2023

Via Benzinga

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗

September 21, 2023

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.

Via Benzinga

Earnings Scheduled For March 14, 2024 ↗

March 14, 2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Via Benzinga

7 Doomed Growth Stocks Destined for Disaster ↗

July 12, 2023

Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell.

Via InvestorPlace

Spectrum Brands, Sanmina And 3 Stocks To Watch Heading Into Friday ↗

May 12, 2023

With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023 ↗

March 20, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.